vs
KALTURA INC（KLTR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是KALTURA INC的1.5倍（$69.8M vs $45.5M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -1.3%，领先385.3%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -0.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 0.8%）
Kaltura Inc是2006年成立、总部位于纽约的软件企业，业务覆盖多个核心领域：网络研讨会与虚拟活动、企业视频内容管理、在线视频平台、教育科技以及云电视软件，可提供视频门户、学习管理系统与内容管理系统扩展插件、虚拟活动与网络研讨会平台、电视流媒体应用等多款产品。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
KLTR vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$45.5M
营收增速更快
RIGL
高出21.3%
-0.1%
净利率更高
RIGL
高出385.3%
-1.3%
两年增速更快
RIGL
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.5M | $69.8M |
| 净利润 | $-575.0K | $268.1M |
| 毛利率 | 72.4% | 91.5% |
| 营业利润率 | 1.9% | 33.2% |
| 净利率 | -1.3% | 384.0% |
| 营收同比 | -0.1% | 21.2% |
| 净利润同比 | 91.3% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KLTRRIGL
| Q4 25 | $45.5M | $69.8M | ||
| Q3 25 | $43.9M | $69.5M | ||
| Q2 25 | $44.5M | $101.7M | ||
| Q1 25 | $47.0M | $53.3M | ||
| Q4 24 | $45.6M | $57.6M | ||
| Q3 24 | $44.3M | $55.3M | ||
| Q2 24 | $44.0M | $36.8M | ||
| Q1 24 | $44.8M | $29.5M |
净利润KLTRRIGL
| Q4 25 | $-575.0K | $268.1M | ||
| Q3 25 | $-2.6M | $27.9M | ||
| Q2 25 | $-7.8M | $59.6M | ||
| Q1 25 | $-1.1M | $11.4M | ||
| Q4 24 | $-6.6M | $14.3M | ||
| Q3 24 | $-3.6M | $12.4M | ||
| Q2 24 | $-10.0M | $-1.0M | ||
| Q1 24 | $-11.1M | $-8.2M |
毛利率KLTRRIGL
| Q4 25 | 72.4% | 91.5% | ||
| Q3 25 | 70.0% | 93.2% | ||
| Q2 25 | 70.2% | 95.6% | ||
| Q1 25 | 69.7% | 91.7% | ||
| Q4 24 | 70.8% | 89.9% | ||
| Q3 24 | 66.7% | 85.5% | ||
| Q2 24 | 65.1% | 92.4% | ||
| Q1 24 | 63.9% | 93.1% |
营业利润率KLTRRIGL
| Q4 25 | 1.9% | 33.2% | ||
| Q3 25 | -3.4% | 40.9% | ||
| Q2 25 | -6.2% | 60.1% | ||
| Q1 25 | -3.4% | 23.9% | ||
| Q4 24 | -8.3% | 28.9% | ||
| Q3 24 | -10.1% | 25.4% | ||
| Q2 24 | -19.4% | 1.2% | ||
| Q1 24 | -16.3% | -23.6% |
净利率KLTRRIGL
| Q4 25 | -1.3% | 384.0% | ||
| Q3 25 | -6.0% | 40.2% | ||
| Q2 25 | -17.4% | 58.6% | ||
| Q1 25 | -2.4% | 21.5% | ||
| Q4 24 | -14.5% | 24.9% | ||
| Q3 24 | -8.1% | 22.5% | ||
| Q2 24 | -22.7% | -2.8% | ||
| Q1 24 | -24.8% | -27.9% |
每股收益（稀释后）KLTRRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $0.02 | $1.46 | ||
| Q2 25 | $-0.05 | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | $0.02 | $0.70 | ||
| Q2 24 | $-0.07 | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.9M | $155.0M |
| 总债务越低越好 | $29.3M | $52.5M |
| 股东权益账面价值 | $6.3M | $391.5M |
| 总资产 | $164.7M | $513.6M |
| 负债/权益比越低杠杆越低 | 4.63× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资KLTRRIGL
| Q4 25 | $51.9M | $155.0M | ||
| Q3 25 | $72.2M | $137.1M | ||
| Q2 25 | $71.2M | $108.4M | ||
| Q1 25 | $62.9M | $77.1M | ||
| Q4 24 | $81.3M | $77.3M | ||
| Q3 24 | $77.7M | $61.1M | ||
| Q2 24 | $68.3M | $49.1M | ||
| Q1 24 | $68.9M | $49.5M |
总债务KLTRRIGL
| Q4 25 | $29.3M | $52.5M | ||
| Q3 25 | $30.6M | $60.0M | ||
| Q2 25 | $31.3M | $60.0M | ||
| Q1 25 | $31.9M | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | $33.3M | $60.0M | ||
| Q2 24 | $33.7M | $60.0M | ||
| Q1 24 | $34.1M | $60.0M |
股东权益KLTRRIGL
| Q4 25 | $6.3M | $391.5M | ||
| Q3 25 | $17.7M | $117.6M | ||
| Q2 25 | $17.0M | $81.9M | ||
| Q1 25 | $22.7M | $18.6M | ||
| Q4 24 | $24.4M | $3.3M | ||
| Q3 24 | $24.1M | $-14.6M | ||
| Q2 24 | $23.5M | $-29.9M | ||
| Q1 24 | $25.1M | $-31.7M |
总资产KLTRRIGL
| Q4 25 | $164.7M | $513.6M | ||
| Q3 25 | $172.6M | $242.5M | ||
| Q2 25 | $169.4M | $206.7M | ||
| Q1 25 | $172.8M | $176.0M | ||
| Q4 24 | $181.3M | $164.0M | ||
| Q3 24 | $178.6M | $139.4M | ||
| Q2 24 | $171.3M | $128.4M | ||
| Q1 24 | $173.1M | $126.5M |
负债/权益比KLTRRIGL
| Q4 25 | 4.63× | 0.13× | ||
| Q3 25 | 1.73× | 0.51× | ||
| Q2 25 | 1.85× | 0.73× | ||
| Q1 25 | 1.41× | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | 1.38× | — | ||
| Q2 24 | 1.43× | — | ||
| Q1 24 | 1.36× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $3.5M | — |
| 自由现金流率自由现金流/营收 | 7.7% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $13.9M | — |
8季度趋势，按日历期对齐
经营现金流KLTRRIGL
| Q4 25 | $3.6M | $22.0M | ||
| Q3 25 | $9.3M | $24.0M | ||
| Q2 25 | $2.7M | $30.5M | ||
| Q1 25 | $-1.0M | $-893.0K | ||
| Q4 24 | $4.3M | $14.5M | ||
| Q3 24 | $10.7M | $21.7M | ||
| Q2 24 | $-1.6M | $302.0K | ||
| Q1 24 | $-1.1M | $-5.0M |
自由现金流KLTRRIGL
| Q4 25 | $3.5M | — | ||
| Q3 25 | $9.2M | — | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $-1.3M | — | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $10.6M | — | ||
| Q2 24 | $-1.8M | — | ||
| Q1 24 | $-1.2M | — |
自由现金流率KLTRRIGL
| Q4 25 | 7.7% | — | ||
| Q3 25 | 20.9% | — | ||
| Q2 25 | 5.7% | — | ||
| Q1 25 | -2.9% | — | ||
| Q4 24 | 9.2% | — | ||
| Q3 24 | 23.9% | — | ||
| Q2 24 | -4.2% | — | ||
| Q1 24 | -2.8% | — |
资本支出强度KLTRRIGL
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.2% | — |
现金转化率KLTRRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KLTR
| Subscription | $42.7M | 94% |
| Professional Services | $2.9M | 6% |
RIGL
暂无分部数据
